|
Publication Information |
Number of Citations |
Address |
| 1 |
Varan, C; Şen, M; Sandler, N; Aktaş, Y; Bilensoy, E, “Mechanical characterization and ex vivo evaluation of anticancer and antiviral drug printed bioadhesive film for the treatment of cervical cancer”, Eur J Pharm Sci., Vol.130, P.114-123, 2019  |
0 |
 |
| 2 |
Ercan, A; Çelebier, M; Varan, G; Öncü, S; Nenni, M; Kaplan, O; Bilensoy, E, “Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells”, Eur J Pharm Sci., Vol.123, P.377-386, 2018 |
0 |
|
| 3 |
Varan, G; Patrulea, V; Borchard, G; Bilensoy, E, “Cellular interaction and tumoral penetration properties of cyclodextrin nanoparticles on 3D breast tumor model”, Nanomaterials (Basel), Vol.8, Is.2, pii.E67, 2018 |
1 |
|
| 4 |
Erdoğar, N; Esendağlı,G; Nielsen, TT; Esendağlı-Yılmaz, G; Yöyen-Ermiş, D; Erdoğdu, B; Sargon, MF; Eroğlu, H; Bilensoy, E, “Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer”, J Drug Target., Vol.26, Is.1, P.66-74, 2018 |
4 |
|
| 5 |
Erdoğar, N; Akkın, S; Bilensoy, E, “Nanocapsules for Drug Delivery: An Updated Review of the Last Decade”, Recent Pat Drug Deliv Formul., Vol.12, Is.4, P.252-266, 2018 |
0 |
|
| 6 |
Karabey-Akyurek, Y; Gurcay, AG; Gurcan, O; Turkoglu, OF; Yabanoglu-Ciftci, S; Eroglu, H; Sargon, MF; Bilensoy, E; Oner, L, “Localized delivery of methylprednisolone sodium succinate with polymeric nanoparticles in experimental injured spinal cord model”, Pharm Dev Technol., Vol.22, Is.8, P.972-981, 2017 |
4 |
|
| 7 |
Varan, G; Varan, C; Erdoğar, N; Bilensoy, E, “Amphiphilic cyclodextrin nanoparticles “, Int J Pharm, Vol.531, Is.2, P.457-459, 2017 |
17 |
|
| 8 |
Varan, C; Wickström, H; Sandler, N; Aktaş, Y; Bilensoy, E, “Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration”, Int J Pharm, Vol.531, Is.2, P.701-713, 2017 |
9 |
|
| 9 |
Karabey-Akyurek, Y; Nemutlu, E; Bilensoy, E; Oner, L, “An Improved and Validated HPLC Method for the Determination of Methylprednisolone Sodium Succinate and its Degradation Products in Nanoparticles”, CURR PHAR A, Vol.13, Is.2, P.162-168, 2017 |
2 |
|
| 10 |
Varan, C; E; Bilensoy, “Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment”, Beilstein J Nanotechnol., Vol.8, P.1446-1456, 2017 |
2 |
|
| 11 |
Erdoğar, N; Varan, G; Bilensoy, E, “Amphiphilic cyclodextrin derivatives for targeted drug delivery to tumors”, Curr Top Med Chem., Vol.17, Is.13, P.1521-1528, 2017 |
8 |
|
| 12 |
Varan, G; Benito, JM; Mellet, CO; Bilensoy, E, “Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery “, Beilstein J Nanotechnol., Vol.8, P.1457-1468, 2017 |
4 |
|
| 13 |
Varan, G; Oncul, S; Ercan, A; Benito, JM; Mellet, CO; Bilensoy, E, “Cholesterol-Targeted Anticancer and Apoptotic Effects of Anionic and Polycationic Amphiphilic Cyclodextrin Nanoparticles”, J PHARM SCI, Vol.105, Is.10, P.3172-3182, 2016 |
6 |
|
| 14 |
Erdogar, N; Esendagli, G; Nielsen, TT; Sen, M; Oner, L; Bilensoy, E, “Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles”, INT J PHARM, Vol.127, Is.1, P.375-390, 2016 |
12 |
|
| 15 |
Aktas, Y; Yenice, K; Bilensoy, E; Hincal, AA, “Amphiphilic cyclodextrins as enabling excipients for drug delivery and for decades of scientific collaboration: Tribute to a distinguished scientist, French representative and friend – A historical perspective”, J DRUG DELI, Vol.30, Is.0, P.261-265, 2015 |
4 |
|
| 16 |
Erdogar, N; Iskit, AB; Eroglu, H; Sargon, MF; Mungan, NA; Bilensoy, E, “Antitumor Efficacy of Bacillus Calmette-Guerin Loaded Cationic Nanoparticles for Intravesical Immunotherapy of Bladder Tumor Induced Rat Model”, J NANOSCI N, Vol.15, Is.12, P.10156-10164, 2015 |
7 |
|
| 17 |
Unal, H; d’Angelo, I; Pagano, E; Borrelli, F; Izzo, A; Ungaro, F; Quaglia, F; Bilensoy, E, “Core-shell hybrid nanocapsules for oral delivery of camptothecin: formulation development, in vitro and in vivo evaluation”, J NANOPAR R, Vol.17, Is.1, P.0-0, 2015 |
14 |
|
| 18 |
Unal, H; Ozturk, N; Bilensoy, E, “Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin”, BEIL J OR C, Vol.11, Is.0, P.204-212, 2015 |
16 |
|
| 19 |
Bilensoy, E, “Amphiphilic cyclodextrin nanoparticles for effective and safe delivery of anticancer drugs”, Adv Exp Med Biol., Vol.822, P.201, 2015 |
6 |
|
| 20 |
Varan, C; Bilensoy, E, “Development of implantable hydroxypropyl-beta-cyclodextrin coated polycaprolactone nanoparticles for the controlled delivery of docetaxel to solid tumors”, J INCL P MA, Vol.80, Is.1, P.9-15, 2014 |
2 |
|
| 21 |
Vranic, E; Grizic, D; Planinsek, O; Srcic, S; Bilensoy, E, “Binary, ternary and microencapsulated celecoxib complexes with beta-cyclodextrin formulated via hydrophilic polymers”, J INCL P MA, Vol.80, Is.1, P.139-146, 2014 |
1 |
|
| 22 |
Erdogar, N; Iskit, AB; Eroglu, H; Sargon, MF; Mungan, NA; Bilensoy, E, “Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: Safety and efficacy”, INT J PHARM, Vol.127, Is.1, P.1-9, 2014 |
4 |
|
| 23 |
Erdogar, N; Iskit, AB; Mungan, NA; Bilensoy, E, “Prolonged retention and in vivo evaluation of cationic nanoparticles loaded with Mitomycin C designed for intravesical chemotherapy of bladder tumours”, J MICROENC, Vol.29, Is.6, P.576-582, 2012 |
7 |
|
| 24 |
Karakas, FP; Karakas, A; Boran, C; Turker, AU; Yalcin, FN; Bilensoy, E, “The evaluation of topical administration of Bellis perennis fraction on circular excision wound healing in Wistar albino rats”, PHARM BIOL, Vol.50, Is.8, P.1031-1037, 2012 |
8 |
|
| 25 |
Bilensoy, E; Moroy, P; Cirpanh, Y; Bilensoy, T; Calis, S; Mollamahmutoglu, L, “A double-blind placebo-controlled study of 5-fluorouracil:cyclodextrin complex loaded thermosensitive gel for the treatment of HPV induced condyloma”, J INCL P MA, Vol.69, Is.3, P.309-313, 2011 |
2 |
|
| 26 |
Cirpanli, Y; Allard, E; Passirani, C; Bilensoy, E; Lemaire, L; Calis, S; Benoit, JP, “Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model”, INT J PHARM, Vol.403, Is.1, P.201-206, 2011 |
36 |
|
| 27 |
Rouf, MA; Vural, I; Bilensoy, E; Hincal, A; Erol, DD, “Rapamycin-cyclodextrin complexation: improved solubility and dissolution rate”, J INCL P MA, Vol.70, Is.1, P.167-175, 2011 |
10 |
|
| 28 |
Yavuz, B; Bilensoy, E; Vural, I; Sumnu, M, “Alternative oral exemestane formulation: Improved dissolution and permeation”, INT J PHARM, Vol.398, Is.1, P.137-145, 2010 |
19 |
|
| 29 |
Cirpanli, Y; Yerlikaya, F; Ozturk, K; Erdogar, N; Launay, M; Gegu, C; Leturgez, T; Bilensoy, E; Calis, S; Capan, Y, “Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles”, PHARMAZIE, Vol.65, Is.12, P.867-870, 2010 |
4 |
|
| 30 |
Erdoğar, N; Mungan, A; Bilensoy, E, “Preparation and characterization of cationic nanoparticles loaded with Mitomycin C by double emulsion and ionotropic gelation techniques”, Journal of controlled release, Vol.148, Is.1, P.e78-79, 2010 |
5 |
|
| 31 |
Cirpanli, Y; Bilensoy, E; Doğan, AL; Çalış, S, “Development of polymeric and cyclodextrin nanoparticles for camptothecin delivery.”, Journal of controlled release, Vol.148, Is.1, P.e21-23, 2010 |
10 |
|
| 32 |
Yavuz, B; Sarısözen, C; Vural, I; Bilensoy, E; Sumnu, M, “An alternative cyclodextrin based formulation for oral anticancer drug exemestane: In vitro and cell culture studies”, Journal of controlled release, Vol.148, Is.1, P.e83-84, 2010 |
3 |
|
| 33 |
Hıncal, AA; Eroğlu, H; Bilensoy, E, “Safety and efficacy of amphiphilic cyclodextrins for drug delivery”, Drug Metab. Rev., Vol.42, Is.1, P.12-13, 2010 |
93 |
|
| 34 |
Bilensoy, E, “Cationic nanoparticles for cancer therapy”, EXP OP DR D, Vol.7, Is.7, P.795-809, 2010 |
26 |
|
| 35 |
Bilensoy, E; Hincal, AA, “Recent advances and future directions in amphiphilic cyclodextrin nanoparticles”, EXP OP DR D, Vol.6, Is.11, P.1161-1173, 2009 |
35 |
|
| 36 |
Cirpanli, Y; Bilensoy, E; Dogan, AL; Calis, S, “Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery”, EUR J PH B, Vol.73, Is.1, P.82-89, 2009 |
54 |
|
| 37 |
Cakmak, A; Cirpanli, Y; Bilensoy, E; Yorganci, K; Calis, S; Saribas, Z; Kaynaroglu, V, “Antibacterial activity of triclosan chitosan coated graft on hernia graft infection model”, INT J PHARM, Vol.381, Is.2, P.214-219, 2009 |
17 |
|
| 38 |
Bilensoy, E; Sarisozen, C; Esendagli, G; Dogan, AL; Aktas, Y; Sen, M; Mungan, NA, “Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors”, INT J PHARM, Vol.371, Is.1, P.170-176, 2009 |
56 |
|
| 39 |
Bilensoy, E; Gurkaynak, O; Dogan, AL; Hincal, AA, “Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery”, INT J PHARM, Vol.347, Is.1, P.163-170, 2008 |
76 |
|
| 40 |
Yenice, I; Mocan, MC; Palaska, E; Bochot, A; Bilensoy, E; Vural, I; Irkec, M; Hincal, AA, “Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea”, EXP EYE RES, Vol.87, Is.3, P.162-167, 2008 |
42 |
|
| 41 |
Bilensoy, E; Gurkaynak, O; Ertan, M; Sen, M; Hincal, AA, “Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel”, J PHARM SCI, Vol.97, Is.4, P.1519-1529, 2008 |
58 |
|
| 42 |
Bilensoy, E, “Nanoparticulate Delivery Systems Based on Amphiphilic Cyclodextrins”, J BIOMED NA, Vol.4, Is.3, P.293-303, 2008 |
15 |
|
| 43 |
Bilensoy, E; Cirpanli, Y; Sen, M; Dogan, AL; Calis, S, “Thermosensitive mucoadhesive gel formulation loaded with 5-Fu: cyclodextrin complex for HPV-induced cervical cancer”, J INCL P MA, Vol.57, Is.1, P.363-370, 2007 |
44 |
|
| 44 |
Bilensoy, E; Dogan, L; Sen, M; Hincal, A, “Complexation behavior of antiestrogen drug tamoxifen citrate with natural and modified beta-cyclodextrins”, J INCL P MA, Vol.57, Is.1, P.651-655, 2007 |
23 |
|
| 45 |
Sarısözen, C; Aktas, Y; Mungan, A; Bilensoy, E, “Bioadhesive coated poly-epsilon-caprolactone nanoparticles loaded with Mitomycin C for the treatment of superficial bladder tumors”, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, Vol.32, Is. 1, P.S36, 2007 |
|
|
| 46 |
Yavuz, B; Bilensoy, E; Şumnu, M, “Bioavailability file: Exemestane”, Fabad Journal of Pharmaceutical Sciences, Vol.32, Is. 2, P.79-89, 2007 |
4 |
|
| 47 |
Bilensoy, E; Rouf, MA; Vural, I; Sen, M; Hincal, AA, “Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: beta-cyclodextrin complex”, AAPS PHARMS, Vol.7, Is.2, P.0-0, 2006 |
111 |
|
| 48 |
Bilensoy, E, “Targeted nanoparticles for cancer therapy”, FEBS JOURNAL, Vol.273, P.35, 2006 |
|
|
| 49 |
Bilensoy, E; Rouf, MA; Vural, I; Hıncal AA, “Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin”, JOURNAL OF CONTROLLED RELEASE, Vol.116, Is.2, P.E107-109, 2006 |
8 |
|
| 50 |
Yavuz, B; Bilensoy, E; Şumnu M, “Analytical method validation for HPLC assay of oral anticancer drug exemestane”, Fabad Journal of Pharmaceutical Sciences, Vol.32, Is.1, P.15-22, 2006 |
3 |
|
| 51 |
Hincal, AA;Bilensoy, E, “Formulation of poorly water soluble drugs with amphiphilic beta cyclodextrins”, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, Vol.28, P.S8-S9, 2006 |
|
|
| 52 |
Memisoglu-Bilensoy, E; Doğan, AL; Hıncal AA, “Cytotoxic evaluation of injectable cyclodextrin nanoparticles”, Journal of Pharmacy and Pharmacology, Vol.58, Is.5, P.585-589, 2006 |
31 |
|
| 53 |
Memisoglu-Bilensoy, E; Hincal, AA, “Sterile, injectable cyclodextrin nanoparticles: Effects of gamma irradiation and autoclaving”, INT J PHARM, Vol.311, Is.1, P.203-208, 2006 |
44 |
|
| 54 |
Memisoglu-Bilensoy, E; Sen, M; Hincal, AA, “Effect of drug physicochemical properties on in vitro characteristics of amphiphilic cyclodextrin nanospheres and nanocapsules”, JOURNAL OF MICROENCAPSULATION, Vol.23, Is.1, P.59-68, 2006 |
26 |
|
| 55 |
Memisoglu-Bilensoy, E; Vural, L; Bochot, A; Renoir, JM; Duchene, D; Hincal, AA, “Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: In vitro characterization and cytotoxicity”, J CONTR REL, Vol.104, Is.3, P.489-496, 2005 |
107 |
|
| 56 |
Memisoglu-Bilensoy, E, “Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: System development and evaluation”, European Journal of Pharmaceutical Sciences, Vol.25, SUPPL. 1, P.54-56, 2005 |
2 |
|
| 57 |
Vural, I; Memisoglu-Bilensoy, E; Renoir, JM; Bochot, A; Duchene, D; Hincal, AA, “Transcription efficiency of tamoxifen citrate-loaded β-cyclodextrin nanoparticles”, Journal of Drug Delivery Science and Technology, Vol.15, Is.5, P.339-342, 2005 |
9 |
|
| 58 |
Memisoglu, E; Vural, L; Bochot, A; Renoir, JM; Duchene, D; Hincal, AA, “Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic β-cyclodextrins”, International Journal of Pharmaceutics, Vol.251, Is.1-2, P.143-153, 2003 |
46 |
|
| 59 |
Memisoglu, E; Bochot, A; Özalp, M; Şen, M; Duchene, D; Hincal, AA, “Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes”, Pharmaceutical Research, Vol.20, Is.1, P.117-125, 2003 |
80 |
|
| 60 |
Ringard-Lefebvre, C; Bochot, A; Memisoglu, E; Charon, D; Duchene, D; Baszkin, A, “Effect of spread amphiphilic β-cyclodextrins on interfacial properties of the oil/water system”, Colloids and Surfaces B: Biointerfaces, Vol.25, Is.2, P.109-117, 2002 |
38 |
|
| 61 |
Memisoglu, E; Bochot, A; En, M; Charon, D; Duchene, D; Hincal, AA, “Amphiphilic β-cyclodextrins modified on the primary face: Synthesis, characterization, and evaluation of their potential as novel excipients in the preparation of nanocapsules”, Journal of Pharmaceutical Sciences, Vol.91, Is.5, P.1214-1224, 2002 |
63 |
|
| 62 |
Memisoglu, E; Öner, F; Ayhan, A; Başaran, I; Hincal, AA, “In vivo evaluation for rhGM-CSF wound-healing efficacy in topical vehicles”, Pharmaceutical Development and Technology, Vol.2, Is.2, P.171-180, 1997 |
10 |
|
